Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice.


Journal

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
ISSN: 1938-2723
Titre abrégé: Clin Appl Thromb Hemost
Pays: United States
ID NLM: 9508125

Informations de publication

Date de publication:
Historique:
entrez: 28 5 2021
pubmed: 29 5 2021
medline: 15 12 2021
Statut: ppublish

Résumé

Uncontrolled bleeding associated with trauma and surgery is the leading cause of preventable death. Batroxobin, a snake venom-derived thrombin-like serine protease, has been shown to clot fibrinogen by cleaving fibrinopeptide A in a manner distinctly different from thrombin, even in the presence of heparin. The biochemical properties of batroxobin and its effect on coagulation have been well characterized

Identifiants

pubmed: 34047195
doi: 10.1177/10760296211018510
pmc: PMC8165871
doi:

Substances chimiques

Hemostatics 0
Batroxobin EC 3.4.21.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10760296211018510

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM105671
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL114405
Pays : United States

Références

Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1381-9
pubmed: 12231555
J Trauma. 2006 Jun;60(6 Suppl):S3-11
pubmed: 16763478
Transfus Apher Sci. 2003 Jun;28(3):257-64
pubmed: 12725952
FEBS Lett. 2004 Jul 30;571(1-3):67-73
pubmed: 15280019
J Thromb Haemost. 2005 May;3(5):875-83
pubmed: 15733060
Thromb Haemost. 1976 Aug 31;36(1):9-13
pubmed: 1036831
J Thromb Haemost. 2005 Aug;3(8):1894-904
pubmed: 16102057
Blood. 2011 Jan 6;117(1):290-8
pubmed: 20864578
J Clin Invest. 2014 Oct;124(10):4281-93
pubmed: 25180602
J Thromb Haemost. 2012 Aug;10(8):1478-85
pubmed: 22632160
J Thromb Haemost. 2005 Aug;3(8):1791-9
pubmed: 16102046
J Intern Med. 2014 Dec;276(6):618-32
pubmed: 25156650
Adv Enzymol Relat Areas Mol Biol. 1979;48:277-318
pubmed: 367103
Thromb Haemost. 2014 Feb;111(2):279-89
pubmed: 24172860
J Thromb Haemost. 2015 Mar;13(3):417-25
pubmed: 25442192
Biomed Mater. 2014 Apr;9(2):025002
pubmed: 24487019
J Thromb Haemost. 2015 Sep;13(9):1694-8
pubmed: 26190406
Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1307-1314
pubmed: 28596377
J Biol Chem. 2000 Aug 18;275(33):25239-46
pubmed: 10837485
Nat Med. 2002 Nov;8(11):1227-34
pubmed: 12411949
Nature. 1978 Oct 12;275(5680):501-5
pubmed: 692730
Biochimie. 2000 Sep-Oct;82(9-10):851-9
pubmed: 11086215
J Biol Chem. 2013 Jun 7;288(23):16862-16871
pubmed: 23612970
Arterioscler Thromb Vasc Biol. 2016 Oct;36(10):2068-77
pubmed: 27470510
J Thromb Haemost. 2011 Jul;9 Suppl 1:195-208
pubmed: 21781256
J Trauma. 2008 Oct;65(4):748-54
pubmed: 18849786
Cardiovasc Hematol Disord Drug Targets. 2012 Dec;12(2):126-32
pubmed: 23030445
Curr Opin Hematol. 2012 Sep;19(5):349-56
pubmed: 22759629
Haemophilia. 2014 May;20 Suppl 4:15-22
pubmed: 24762270
Blood. 2004 Sep 15;104(6):1753-9
pubmed: 15178583
J Thromb Haemost. 2010 Sep;8(9):1919-25
pubmed: 20553376
J Thromb Haemost. 2006 Oct;4(10):2230-7
pubmed: 16824188
Arterioscler Thromb Vasc Biol. 2017 Oct;37(10):1828-1839
pubmed: 28775075
Pathophysiol Haemost Thromb. 2005;34(4-5):200-4
pubmed: 16707928
Biochem J. 2006 Aug 1;397(3):377-87
pubmed: 16831131
Toxicon. 2010 Apr 1;55(4):745-53
pubmed: 19931298
Pharmacotherapy. 2007 Sep;27(9 Pt 2):45S-56S
pubmed: 17723108
J Thromb Haemost. 2003 Jul;1(7):1628-36
pubmed: 12871299
J Thromb Thrombolysis. 2010 Oct;30(3):332-9
pubmed: 20464453
Crit Care. 2010;14(2):R52
pubmed: 20370902
Crit Care. 2016 Apr 12;20:100
pubmed: 27072503
Toxicon. 2017 Jun 1;131:37-47
pubmed: 28288936
Toxicon. 2013 Feb;62:19-26
pubmed: 23010164
N Engl J Med. 1991 May 30;324(22):1565-74
pubmed: 2027360
Blood. 2007 Jun 15;109(12):5087-95
pubmed: 17311994
J Clin Invest. 2000 Aug;106(3):385-92
pubmed: 10930441
Prostaglandins Other Lipid Mediat. 2018 Nov;139:10-18
pubmed: 30266534
Biochemistry. 1987 Feb 10;26(3):780-7
pubmed: 3552032
Blood. 2009 Feb 19;113(8):1809-17
pubmed: 19036705

Auteurs

Reheman Adili (R)

Department of Pharmacology, 1259University of Michigan, Ann Arbor, MI, USA.

Madeline Jackson (M)

Department of Pharmacology, 1259University of Michigan, Ann Arbor, MI, USA.

Livia Stanger (L)

Department of Pharmacology, 1259University of Michigan, Ann Arbor, MI, USA.

Xiangrong Dai (X)

Zhaoke Pharmaceutical (Hefei) Co. Limited, Hefei, Anhui, China.

Mandy Li (M)

Lee's Pharmaceutical Holdings Limited. Shatin, Hong Kong, China.

Benjamin Xiaoyi Li (BX)

Lee's Pharmaceutical Holdings Limited. Shatin, Hong Kong, China.

Michael Holinstat (M)

Department of Pharmacology, 1259University of Michigan, Ann Arbor, MI, USA.
Department of Internal Medicine, Division of Cardiovascular Medicine, 1259University of Michigan, Ann Arbor, MI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH